Nephrocare Healt

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE428V01029
  • NSEID: NEPHROPLUS
  • BSEID: 544647
INR
658.30
16.4 (2.55%)
BSENSE

Nov 20

BSE+NSE Vol: 1.16 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
303.40
281.75
265.62
259.73
245.72
227.78
219.19
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
303.40
281.75
265.62
259.73
245.72
227.78
219.19
Raw Material Cost
66.25
62.44
59.63
58.52
54.17
54.47
53.52
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
52.87
47.83
45.93
43.10
42.96
39.80
34.21
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
55.32
52.20
50.53
50.67
47.93
43.01
42.38
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
61.84
55.40
55.75
46.58
36.73
42.94
37.78
Total Expenditure (Excl Depreciation)
236.28
217.87
211.84
198.87
181.79
180.22
167.89
Operating Profit (PBDIT) excl Other Income
67.12
63.88
53.78
60.86
63.93
47.56
51.30
Other Income
8.00
7.46
11.57
3.32
3.89
6.58
4.11
Operating Profit (PBDIT)
75.12
71.34
65.35
64.18
67.82
54.14
55.41
Interest
3.11
2.21
3.18
5.96
45.00
6.10
6.12
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
72.01
69.13
62.17
58.22
22.82
48.04
49.29
Depreciation
27.68
24.54
25.85
21.86
23.44
19.52
19.38
Profit Before Tax
40.41
41.03
33.22
36.36
-0.62
28.52
29.92
Tax
6.88
9.06
2.85
4.12
8.85
4.82
5.06
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
37.45
35.54
33.46
32.24
-9.47
23.70
24.87
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
37.45
35.54
33.46
32.24
-9.47
23.70
24.87
Share in Profit of Associates
-3.92
-3.57
-3.09
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
33.53
31.97
30.37
32.24
-9.47
23.70
24.87
Equity Capital
20.11
20.07
20.07
20.07
3.62
20.07
1.77
Face Value
2.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
3.33
15.93
15.13
16.06
-26.16
11.81
140.51
Diluted Earnings per share
3.25
15.93
2.96
3.35
-26.18
2.7
2.95
Operating Profit Margin (Excl OI)
22.12%
22.67%
20.25%
23.43%
26.02%
20.88%
23.4%
Gross Profit Margin
23.73%
24.54%
23.41%
22.42%
9.29%
21.09%
22.49%
PAT Margin
11.05%
11.35%
11.43%
12.41%
-3.85%
10.4%
11.35%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 3.64% vs 3.68% in Jun 2026

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Sep 2026 is 13.93% vs 15.34% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 3.56% vs 9.38% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is 36.73% vs -61.42% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

Compare Quarterly Results Of Nephrocare Healt With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
303.40
1.20
302.20
25,183.33%
Other Operating Income
0.00
0.00
0.00
Total Operating income
303.40
1.20
302.20
25,183.33%
Raw Material Cost
66.25
0.00
66.25
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
52.87
7.19
45.68
635.33%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
55.32
0.00
55.32
Selling and Distribution Expenses
0.00
100.30
-100.30
-100.00%
Other Expenses
61.84
4.63
57.21
1,235.64%
Total Expenditure (Excl Depreciation)
236.28
112.12
124.16
110.74%
Operating Profit (PBDIT) excl Other Income
67.12
-110.92
178.04
160.51%
Other Income
8.00
6.73
1.27
18.87%
Operating Profit (PBDIT)
75.12
-104.19
179.31
172.10%
Interest
3.11
0.46
2.65
576.09%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
72.01
-104.65
176.66
168.81%
Depreciation
27.68
2.30
25.38
1,103.48%
Profit Before Tax
40.41
-106.94
147.35
137.79%
Tax
6.88
0.00
6.88
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
37.45
-106.94
144.39
135.02%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
37.45
-106.94
144.39
135.02%
Share in Profit of Associates
-3.92
0.00
-3.92
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
33.53
-106.94
140.47
131.35%
Equity Capital
20.11
28.26
-8.15
-28.84%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
3.33
-3.78
7.11
188.10%
Diluted Earnings per share
3.25
-3.77
7.02
186.21%
Operating Profit Margin (Excl OI)
22.12%
-9,243.33%
0.00
9,265.45%
Gross Profit Margin
23.73%
-8,720.83%
0.00
8,744.56%
PAT Margin
11.05%
-8,911.67%
0.00
8,922.72%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 176.58 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 3.64% vs 3.68% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 13.25%

Quarterly - Standalone Net Profit
Standalone Net Profit 14.31 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 13.93% vs 15.34% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 144.15%

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 25.01 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 3.56% vs 9.38% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 6.56%

Quarterly - Interest
Interest 0.67 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 36.73% vs -61.42% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -98.37%

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.16%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025